Real-World Data About Treatment Pattern and Outcomes of Patients With Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma in France: Results From the Fregat Database - Université de Picardie Jules Verne
Article Dans Une Revue Value in Health Année : 2022

Real-World Data About Treatment Pattern and Outcomes of Patients With Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma in France: Results From the Fregat Database

Résumé

Esophageal cancer is the seventh most common cancer and sixth leading cause of cancer death, worldwide, with approximately 600,000 new cases and over 540,000 deaths in 2020. Squamous-cell carcinoma accounts for approximately 60% of cases in Europe. The study aim was to describe real-world treatment and outcomes of French patients presenting with UnResectable Advanced, or Metastatic Esophageal Squamous-Cell Carcinoma (URAM-ESCC) from 2014 to 2019 before approval of immune-checkpoint inhibitors (ICI).

Domaines

Médecine humaine et pathologie

Louise DESSAIVRE  : Connectez-vous pour contacter le contributeur

https://u-picardie.hal.science/hal-04031810

Soumis le : jeudi 16 mars 2023-10:55:18

Dernière modification le : jeudi 7 novembre 2024-16:14:04

Fichier non déposé

Dates et versions

hal-04031810 , version 1 (16-03-2023)

Identifiants

Citer

G Piessen, A Adenis, F Renaud, S Devaux, D Bergeat, et al.. Real-World Data About Treatment Pattern and Outcomes of Patients With Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma in France: Results From the Fregat Database. Value in Health, 2022, 25 (12), pp.S473 ; RWD123. ⟨10.1016/j.jval.2022.09.2348⟩. ⟨hal-04031810⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CEA FNCLCC VALDAURELLE LAMBRET DSM-IRFU CEA-UPSAY UNIV-PARIS-SACLAY UNIV-MONTPELLIER CEA-DRF UNIV-LILLE IRCM U-PICARDIE SSPC
53 Consultations
0 Téléchargements

Altmetric

Partager

More